000 | 01539 a2200409 4500 | ||
---|---|---|---|
005 | 20250517001248.0 | ||
264 | 0 | _c20160108 | |
008 | 201601s 0 0 eng d | ||
022 | _a1932-6203 | ||
024 | 7 |
_a10.1371/journal.pone.0111412 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aCalik, Michael W | |
245 | 0 | 0 |
_aCannabinoid type 1 and type 2 receptor antagonists prevent attenuation of serotonin-induced reflex apneas by dronabinol in Sprague-Dawley rats. _h[electronic resource] |
260 |
_bPloS one _c2014 |
||
300 |
_ae111412 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, N.I.H., Extramural | ||
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aCannabinoid Receptor Agonists _xchemistry |
650 | 0 | 4 |
_aDronabinol _xchemistry |
650 | 0 | 4 | _aElectromyography |
650 | 0 | 4 |
_aFemoral Vein _xpathology |
650 | 0 | 4 |
_aIndoles _xchemistry |
650 | 0 | 4 | _aMale |
650 | 0 | 4 |
_aNodose Ganglion _xdrug effects |
650 | 0 | 4 |
_aPiperidines _xchemistry |
650 | 0 | 4 |
_aPyrazoles _xchemistry |
650 | 0 | 4 | _aRats |
650 | 0 | 4 | _aRats, Sprague-Dawley |
650 | 0 | 4 |
_aReceptor, Cannabinoid, CB1 _xantagonists & inhibitors |
650 | 0 | 4 |
_aReceptor, Cannabinoid, CB2 _xantagonists & inhibitors |
650 | 0 | 4 |
_aSerotonin _xadministration & dosage |
650 | 0 | 4 |
_aSleep Apnea, Obstructive _xchemically induced |
650 | 0 | 4 | _aTreatment Outcome |
700 | 1 | _aCarley, David W | |
773 | 0 |
_tPloS one _gvol. 9 _gno. 10 _gp. e111412 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1371/journal.pone.0111412 _zAvailable from publisher's website |
999 |
_c24310955 _d24310955 |